Nanoliposomal Eucommia ulmoides extract limits PANoptosis in sepsis‐induced acute lung injury through a TGF‐β1–JNK pathway
British Journal of Pharmacology · 2026-08 · 183 (15) · 4381-4398
DOI: 10.1111/bph.70393 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 29.04.2026. Verfasst von Mingtao Deng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Shangrao Key Laboratory of Acute and Critical Care Medicine, The Central Hospital of Shangrao, The First Affili…. Hauptthemen laut MEDLINE: Acute Lung Injury, Sepsis, Eucommiaceae, Transforming Growth Factor beta1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Science and Technology Program of Jiangxi Administration of Traditional Chinese Medicine, Fujian Province Science and Technology Innovation Joint Funding Project, Natural Science Foundation of Jiangxi Province.
Themen: Sepsis
Abstract (Originalsprache)
Background and purpose Sepsis‐induced acute lung injury (ALI) is driven by macrophage‐mediated inflammation and PANoptosis. Eucommia ulmoides Oliv. (Du Zhong, DZ) contains anti‐inflammatory phytochemicals, but crude extracts show poor solubility, rapid clearance and a narrow therapeutic window. We therefore tested whether a nanoliposomal DZ formulation (Nano‐LP‐DZ) could improve efficacy in experimental sepsis‐induced ALI. Experimental approach Nano‐LP‐DZ was prepared by double‐emulsion ultrasonication and characterised physicochemically. Its effects were evaluated in lipopolysaccharide‐stimulated macrophages, macrophages stimulated with Oxo plus lipopolysaccharide, and in mice subjected to caecal ligation and puncture (CLP). Cytokine release, lung injury and macrophage survival were assessed together with markers of pyroptosis, apoptosis and necroptosis. Upstream regulation was examined using TGF‐β1 knockdown, TGF‐β receptor blockade, JNK inhibition, and transcriptomic analyses. Key Results Compared with the unformulated extract, Nano‐LP‐DZ preserved macrophage viability at pharmacologically active concentrations, more effectively reduced interleukin‐1β, interleukin‐6 and tumour necrosis factor‐α release, and alleviated CLP‐induced lung oedema, neutrophil infiltration and histopathological damage. Nano‐LP‐DZ restored TGF‐β1 expression in macrophages under septic stress and induced phosphorylation of JNK and its substrate Bim. These changes were accompanied by suppression of PANoptosis, with reduced caspase‐1, gasdermin D and E, caspase‐8, caspase‐3, caspase‐7 and phospho‐MLKL signalling. Silencing TGF‐β1, blocking its receptor or inhibiting JNK markedly inhibited these protective effects. Conclusions and implications Nano‐LP‐DZ broadens the therapeutic window and enhances the anti‐inflammatory efficacy of DZ in sepsis‐induced ALI by engaging a macrophage TGF‐β1–JNK pathway that restrains PANoptosis. These findings identify TGF‐β1–JNK as a druggable upstream checkpoint in sepsis‐associated lung injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Shangrao Key Laboratory of Acute and Critical Care Medicine, The Central Hospital of Shangrao, The First Affiliated Hospital of Jiangxi Medical College, Shangrao, China.
- Department of Medical Technology, Jiangxi Medical College, Shangrao, China.
- College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
- School of Information Science and Engineering, Fudan University, Shanghai, China.
- Department of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fujian Provincial Center for Critical Ca…
- Department of Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Förderung
- Science and Technology Program of Jiangxi Administration of Traditional Chinese Medicine
- Fujian Province Science and Technology Innovation Joint Funding Project
- Natural Science Foundation of Jiangxi Province
- Science and Technology Program of Jiangxi Provincial Health Commission
- Project Supported by the Scientific Research Fund of Jiangxi Provincial Education Department
Zitieren
APA
Deng, M., Tong, Z., Li, X., Chen, S., Wu, J., Dai, J., Xu, J., Li, M., Cao, L., Weng, X., Wang, J., Zeng, L., Gong, Y., Gao, Y., Shang, X., & Dai, W. (2026). Nanoliposomal Eucommia ulmoides extract limits PANoptosis in sepsis‐induced acute lung injury through a TGF‐β1–JNK pathway. British Journal of Pharmacology, 183(15), 4381-4398. https://doi.org/10.1111/bph.70393
Vancouver
Deng M, Tong Z, Li X, Chen S, Wu J, Dai J, et al. Nanoliposomal Eucommia ulmoides extract limits PANoptosis in sepsis‐induced acute lung injury through a TGF‐β1–JNK pathway. British Journal of Pharmacology. 2026;183(15):4381-4398. doi:10.1111/bph.70393
BibTeX
@article{Deng2026,
author = {Deng, Mingtao and Tong, Zheren and Li, Xin and Chen, Siqi and Wu, Jian and Dai, Jiaheng and Xu, Jingqing and Li, Min and Cao, Liu and Weng, Xinhui and Wang, Jingwei and Zeng, Long and Gong, Yuanqi and Gao, Yi and Shang, Xiuling and Dai, Wei},
title = {Nanoliposomal Eucommia ulmoides extract limits PANoptosis in sepsis‐induced acute lung injury through a TGF‐β1–JNK pathway},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {15},
pages = {4381--4398},
doi = {10.1111/bph.70393}
}
EUVIMED